Signal Peptide Database - Drosophila melanogaster

 Entry Details
ID   8800
Source Database   UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number   O97394    (Created: 2006-03-07 Updated: 2008-12-16)
UniProtKB/Swiss-Prot Entry Name   SDK_DROME
Protein Name   Protein sidekick
Gene   sdk
Organism Scientific   Drosophila melanogaster
Organism Common   Fruit fly
Lineage   Eukaryota
  Metazoa
    Arthropoda
      Hexapoda
        Insecta
          Pterygota
            Neoptera
              Endopterygota
                Diptera
                  Brachycera
                    Muscomorpha
                      Ephydroidea
                        Drosophilidae
                          Drosophila
                            Sophophora
Protein Length [aa]   2224
Protein Mass [Da]   246254
Features  
TypeDescriptionStatusStartEnd
signal peptide      potential   1   47
chain   Protein sidekick      48   2224
disulfide bond      by similarity   95   138
disulfide bond      by similarity   283   336
disulfide bond      by similarity   382   433
disulfide bond      by similarity   476   525
disulfide bond      by similarity   567   620
transmembrane region      potential   2002   2022
topological domain   Extracellular   potential   48   2001
topological domain   Cytoplasmic   potential   2023   2224
domain   Ig-like C2-type 1      72   155
domain   Ig-like C2-type 2      261   355
domain   Ig-like C2-type 3      359   445
domain   Ig-like C2-type 4      455   541
domain   Ig-like C2-type 5      546   636
domain   Fibronectin type-III 1      641   748
domain   Fibronectin type-III 2      755   852
domain   Fibronectin type-III 3      857   964
domain   Fibronectin type-III 4      969   1060
domain   Fibronectin type-III 5      1067   1159
domain   Fibronectin type-III 6      1166   1267
domain   Fibronectin type-III 7      1272   1367
domain   Fibronectin type-III 8      1374   1465
domain   Fibronectin type-III 9      1472   1567
domain   Fibronectin type-III 10      1572   1672
domain   Fibronectin type-III 11      1679   1782
domain   Fibronectin type-III 12      1787   1879
domain   Fibronectin type-III 13      1886   1979
modified residue   Phosphoserine      2071   2071
modified residue   Phosphothreonine      2074   2074
modified residue   Phosphoserine      2113   2113
modified residue   Phosphoserine      2117   2117
glycosylation site   N-linked (GlcNAc...)   potential   164   164
glycosylation site   N-linked (GlcNAc...)   potential   250   250
glycosylation site   N-linked (GlcNAc...)   potential   318   318
glycosylation site   N-linked (GlcNAc...)   potential   327   327
glycosylation site   N-linked (GlcNAc...)   potential   463   463
glycosylation site   N-linked (GlcNAc...)   potential   485   485
glycosylation site   N-linked (GlcNAc...)   potential   491   491
glycosylation site   N-linked (GlcNAc...)   potential   628   628
glycosylation site   N-linked (GlcNAc...)   potential   661   661
glycosylation site   N-linked (GlcNAc...)   potential   707   707
glycosylation site   N-linked (GlcNAc...)   potential   809   809
glycosylation site   N-linked (GlcNAc...)      870   870
glycosylation site   N-linked (GlcNAc...)   potential   942   942
glycosylation site   N-linked (GlcNAc...)   potential   1019   1019
glycosylation site   N-linked (GlcNAc...)   potential   1094   1094
glycosylation site   N-linked (GlcNAc...)   potential   1109   1109
glycosylation site   N-linked (GlcNAc...)   potential   1172   1172
glycosylation site   N-linked (GlcNAc...)   potential   1203   1203
glycosylation site   N-linked (GlcNAc...)   potential   1282   1282
glycosylation site   N-linked (GlcNAc...)   potential   1329   1329
glycosylation site   N-linked (GlcNAc...)   potential   1379   1379
glycosylation site   N-linked (GlcNAc...)   potential   1414   1414
glycosylation site   N-linked (GlcNAc...)   potential   1420   1420
glycosylation site   N-linked (GlcNAc...)   potential   1843   1843
glycosylation site   N-linked (GlcNAc...)   potential   1876   1876
splice variant   (in isoform C)      0   0
compositionally biased region   Poly-Gln      65   70
SP Length   47
 ----+----1----+----2----+----3----+----4----+----5
Signal Peptide MLKSAASSLRRRRPKTTITATLAIEMPSQPKLASLLAVLVLLCYCDS
Sequence MLKSAASSLRRRRPKTTITATLAIEMPSQPKLASLLAVLVLLCYCDSCFF
CYADANLQQQNSIV
QQQQLQAPRFTTHPSSSGSIVSEGSTKILQCHALGY
PQPTYRWLKDGVPVGDFSSSQFYRFHSTRREDAGSYQCIARNDAGSIFSE
KSDVV
VAYMGIFENTTEGRLTVISGHPAIFDMPPIESIPVPSVMWQSEDG
PLNYDIKYAFTHANQLIILSADENDRKGYRAKAINTQLGKEESSAFVHL
N
VSGDPYIEVAPEIIVRPQDVKVKVGTGVVELQCIANARPLHELETLWLKD
GLAVETAGVRHTLNDPW
NRTLALLQANSSHSGEYTCQVRLRSGGYPAVSA
SARLQ
ILEPPLFFTPMRAETFGEFGGQVQLTCDVVGEPTPQVKWFRNAES
VDAHIESGRYTLNTDNTLVIKKLILDDAAMFQCLAINEAGENSAS
TWLRV
KTSA
PIMELPPQNVTALDGKDATISCRAVGSPNPNITWIYNETQLVDISS
RVQILESGDLLISNIRSVDAGLYICVRANEAGSVKGEAYLS
VLVRTQIIQ
PPVDTTVLLGLTATLQCKVSSDPSVPYNIDWYREGQSSTPISNSQRIGVQ
ADGQLEIQAVRASDVGSYACVVTSPGG
NETRAARLSVIELPFPPSNVKVE
RLPEPQQRSI
NVSWTPGFDGNSPISKFIIQRREVSELEKFVGPVPDPLLN
WITELS
NVSADQRWILLENLKAATVYQFRVSAVNRVGEGSPSEPSNVVEL
PQEA
PSGPPVGFVGSARSMSEIITQWQPPLEEHRNGQILGYILRYRLFGY
NNVPWSYQ
NITNEAQRNFLIQELITWKDYIVQIAAYNNMGVGVYTEGSKI
KT
KEGVPEAPPTNVKVEAINSTAARCRWTPPNPQQINGINQGYKIQAWQR
RLIDGEWRDIERRMKTVPPSLIDPLAEQTAILGGLEKFTEY
NISVLCFTD
PGDGVASSQVAVMT
MDDVPDEVTGLHFDDVSDRSVKVLWAPPRASNGILT
GYTVRYQVKDRPDTLKSF
NLTADDTELTVNQLQATTHYWFEIVAWTRVGS
GIPKTATIQS
GVEPVLPHAPTALALSNIEAFSVVLQFTPGFDGNSSITKW
KVEGQTAR
NMTWFTICEINDPDAETLTVTGLVPFTQYRLRLSASNVVGSS
KPSEATKDF
QTIQARPKHPPFNVTVRAMSAQQLRVRWIPLQQTEWYGNPR
GY
NISYKQLVKTPGTIKYVPRSVVIEDHTANSHVLDSLEEWTLYEVKMNA
CNDVGCSKESDTAVERT
REAVPSYGPLDVQANATSSTTVVVQWGEVPRQH
RNGQIDGYKVFYAAADRGQQVLHKTIPN
NATFTTTLTELKKYVVYHVQVL
AYTRLGNGALSTPPIRV
QTFEDTPGVPSNVSFPDVSLTMARIIWDVPVDP
NGKILAYQVTYTL
NGSAMLNYSREFPPSDRTFRATELLPGKYYSFSCTAQ
TRLGWGKIATALVYT
TNNRERPQAPSVPQISRSQIQAHQITFSWTPGRDG
FAPLRYYTVEMRENEGRWQPLPERVDPSLSSFTAVGLRPYMTYQFRIQAT
NDLGPSAFSRESVIVRT
LPAAPAVGVGGLKVVPITTTSVRVQWSALETAL
WNGDASTGGYRILYQQLSDFPTALQSTPKTDVHGINENSVVLSDLQQDRN
YEIVVLPFNSQGPGPATPPAAV
YVGEAVPTGEPRAVDAAPISSTEVRLLW
KPPKQSMQNGDILGYKIYYLVTYSPQALEPGRKWEEEIEVVSATATSHSL
VFLDKFTEYRIQLLAFNPAGDGPRSAPITVKT
LPGVPSAPLHLRFSDITM
QSLEVTWDPPKFLNGEILGYLVTYETTEENEKFSKQVKQKVS
NTTLRVQN
LEEEVTYTFTVRAQTSVDYGPGISE
NVTTGPQDGSPVAPRDLILTKTLSS
VEMHWINGPSGRGPILGYLIEAKKRDDSRWTKIEQTRKGMMQDFTVSYHI
LMPSTAYTFRVIAYNRYGISFPVYSKDSI
LTPSKLHLEYGYLQHKPFYRQ
T
WFMVSLAATSIVIIVMVIAVLCVKSKSYKYKQEAQKTLEESMAMSIDER
QELALELYRSRHGVGTGTLN
SVGTLRSGTLGTLGRKSTSRPPPGVHLGKS
PPRPSPASVAYH
SDEESLKCYDENPDDSSVTEKPSEVSSSEASQHSESEN
ESVRSDPHSFVNHYANVNDSLRQSWKKTKPVRNYSSYTDSEPEGSAVMSL
NGGQIIVNNMARSRAPLPGFSSFV
Original MLKSAASSLRRRRPKTTITATLAIEMPSQPKLASLLAVLVLLCYCDSCFF
CYADANLQQQNSIVQQQQLQAPRFTTHPSSSGSIVSEGSTKILQCHALGY
PQPTYRWLKDGVPVGDFSSSQFYRFHSTRREDAGSYQCIARNDAGSIFSE
KSDVVVAYMGIFENTTEGRLTVISGHPAIFDMPPIESIPVPSVMWQSEDG
PLNYDIKYAFTHANQLIILSADENDRKGYRAKAINTQLGKEESSAFVHLN
VSGDPYIEVAPEIIVRPQDVKVKVGTGVVELQCIANARPLHELETLWLKD
GLAVETAGVRHTLNDPWNRTLALLQANSSHSGEYTCQVRLRSGGYPAVSA
SARLQILEPPLFFTPMRAETFGEFGGQVQLTCDVVGEPTPQVKWFRNAES
VDAHIESGRYTLNTDNTLVIKKLILDDAAMFQCLAINEAGENSASTWLRV
KTSAPIMELPPQNVTALDGKDATISCRAVGSPNPNITWIYNETQLVDISS
RVQILESGDLLISNIRSVDAGLYICVRANEAGSVKGEAYLSVLVRTQIIQ
PPVDTTVLLGLTATLQCKVSSDPSVPYNIDWYREGQSSTPISNSQRIGVQ
ADGQLEIQAVRASDVGSYACVVTSPGGNETRAARLSVIELPFPPSNVKVE
RLPEPQQRSINVSWTPGFDGNSPISKFIIQRREVSELEKFVGPVPDPLLN
WITELSNVSADQRWILLENLKAATVYQFRVSAVNRVGEGSPSEPSNVVEL
PQEAPSGPPVGFVGSARSMSEIITQWQPPLEEHRNGQILGYILRYRLFGY
NNVPWSYQNITNEAQRNFLIQELITWKDYIVQIAAYNNMGVGVYTEGSKI
KTKEGVPEAPPTNVKVEAINSTAARCRWTPPNPQQINGINQGYKIQAWQR
RLIDGEWRDIERRMKTVPPSLIDPLAEQTAILGGLEKFTEYNISVLCFTD
PGDGVASSQVAVMTMDDVPDEVTGLHFDDVSDRSVKVLWAPPRASNGILT
GYTVRYQVKDRPDTLKSFNLTADDTELTVNQLQATTHYWFEIVAWTRVGS
GIPKTATIQSGVEPVLPHAPTALALSNIEAFSVVLQFTPGFDGNSSITKW
KVEGQTARNMTWFTICEINDPDAETLTVTGLVPFTQYRLRLSASNVVGSS
KPSEATKDFQTIQARPKHPPFNVTVRAMSAQQLRVRWIPLQQTEWYGNPR
GYNISYKQLVKTPGTIKYVPRSVVIEDHTANSHVLDSLEEWTLYEVKMNA
CNDVGCSKESDTAVERTREAVPSYGPLDVQANATSSTTVVVQWGEVPRQH
RNGQIDGYKVFYAAADRGQQVLHKTIPNNATFTTTLTELKKYVVYHVQVL
AYTRLGNGALSTPPIRVQTFEDTPGVPSNVSFPDVSLTMARIIWDVPVDP
NGKILAYQVTYTLNGSAMLNYSREFPPSDRTFRATELLPGKYYSFSCTAQ
TRLGWGKIATALVYTTNNRERPQAPSVPQISRSQIQAHQITFSWTPGRDG
FAPLRYYTVEMRENEGRWQPLPERVDPSLSSFTAVGLRPYMTYQFRIQAT
NDLGPSAFSRESVIVRTLPAAPAVGVGGLKVVPITTTSVRVQWSALETAL
WNGDASTGGYRILYQQLSDFPTALQSTPKTDVHGINENSVVLSDLQQDRN
YEIVVLPFNSQGPGPATPPAAVYVGEAVPTGEPRAVDAAPISSTEVRLLW
KPPKQSMQNGDILGYKIYYLVTYSPQALEPGRKWEEEIEVVSATATSHSL
VFLDKFTEYRIQLLAFNPAGDGPRSAPITVKTLPGVPSAPLHLRFSDITM
QSLEVTWDPPKFLNGEILGYLVTYETTEENEKFSKQVKQKVSNTTLRVQN
LEEEVTYTFTVRAQTSVDYGPGISENVTTGPQDGSPVAPRDLILTKTLSS
VEMHWINGPSGRGPILGYLIEAKKRDDSRWTKIEQTRKGMMQDFTVSYHI
LMPSTAYTFRVIAYNRYGISFPVYSKDSILTPSKLHLEYGYLQHKPFYRQ
TWFMVSLAATSIVIIVMVIAVLCVKSKSYKYKQEAQKTLEESMAMSIDER
QELALELYRSRHGVGTGTLNSVGTLRSGTLGTLGRKSTSRPPPGVHLGKS
PPRPSPASVAYHSDEESLKCYDENPDDSSVTEKPSEVSSSEASQHSESEN
ESVRSDPHSFVNHYANVNDSLRQSWKKTKPVRNYSSYTDSEPEGSAVMSL
NGGQIIVNNMARSRAPLPGFSSFV
 ----+----1----+----2----+----3----+----4----+----5
Hydropathies  
 

© 2007-2017 Dr. Katja Kapp, Kassel & thpr.net e. K., Dresden, Germany, last update 2010-06-11